Provided by Tiger Trade Technology Pte. Ltd.

AstraZeneca PLC

162.70
-1.8200-1.11%
Post-market: 161.65-1.0452-0.64%19:43 EDT
Volume:2.88M
Turnover:468.05M
Market Cap:252.35B
PE:24.36
High:163.54
Open:163.52
Low:161.18
Close:164.52
52wk High:212.71
52wk Low:145.79
Shares:1.55B
Float Shares:1.50B
Volume Ratio:0.99
T/O Rate:0.19%
Dividend:3.16
Dividend Rate:1.94%
EPS(TTM):6.68
EPS(LYR):6.54
ROE:21.96%
ROA:8.02%
PB:5.02
PE(LYR):24.88

Loading ...

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 11

$400 Billion Merger Talks Collapse: AstraZeneca and Bristol-Myers Squibb Negotiations Fall Apart

Deep News
·
Aug 11

AstraZeneca PLC Stock Rises Monday, Outperforms Market

Dow Jones
·
Aug 11

Vertex Pharmaceuticals Inc Stock (VRTX) Opened Up by 9.76% on Aug 10: What Investors Need To Know

TradingKey
·
Aug 10

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 10

AstraZeneca PLC Stock Falls Thursday, Underperforms Market

Dow Jones
·
Aug 07

AstraZeneca May Abandon Decade-Long M&A Strategy, Pursuing Mega Deal to Secure US Market Scale

Deep News
·
Aug 06

Deal or no Deal, AstraZeneca Stock is a Bargain

Dow Jones
·
Aug 06

AstraZeneca, Jaguar Land Rover Gain Access to UK's Fast-Track Visa

MT Newswires Live
·
Aug 06

Wall Street Warms to Healthcare Stocks as Tech Trade Faces Turbulence

Reuters
·
Aug 05

Unusually active option classes on open August 5th

TIPRANKS
·
Aug 05

Bristol Myers, AstraZeneca not engaged in merger talks, Reuters reports

TIPRANKS
·
Aug 05

AstraZeneca PLC Stock (AZN) Moved Up by 4.30% on Aug 5: A Full Analysis

TradingKey
·
Aug 05

Movement Alert|AstraZeneca PLC Rises 4.97% in Regular Trading, Rebound After Bristol Myers Merger Rumor Officially Denied

Market Focus
·
Aug 05

Market Chatter: AstraZeneca, Bristol Myers Not Pursuing Merger Talks

MT Newswires Live
·
Aug 05

Movement Alert|AstraZeneca PLC Pre-Market Rise 4.77%, Stock Recovers as Multiple Banks Question Feasibility of Bristol-Myers Squibb Merger

Market Focus
·
Aug 05

AstraZeneca deal talks with Bristol Myers remain active, Semafor says

TIPRANKS
·
Aug 05

AstraZeneca Advances Tuesday, Outperforms Market

Dow Jones
·
Aug 05

Bristol Myers Squibb Potential Deal With AstraZeneca Seen Unlikely as Shareholder Views Diverge, RBC Says

MT Newswires Live
·
Aug 04

AstraZeneca (AZN) Gets a Sell from Deutsche Bank

TIPRANKS
·
Aug 04